Daclizumab and cardio-respiratory arrest Patient Reports February 12, 2012

Daclizumab Side Effects Report #5293398-6
Daclizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: acinetobacter infection, alopecia, blood triglycerides increased, cardio-respiratory arrest, dysphagia, dysphonia, enterococcal infection, haematocrit decreased, haemoglobin decreased. Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5307601-7
Daclizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: acinetobacter infection, anaemia, blood calcium decreased, blood phosphorus decreased, blood triglycerides increased, cardio-respiratory arrest, dysphagia, dysphonia, enterococcal infection. Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5317038-2
Daclizumab side effect was reported by a Health Professional from UNITED STATES on May 01, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, interstitial lung disease, meningitis , pyrexia. Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5319054-3
Daclizumab side effect was reported by a Health Professional from UNITED STATES on May 02, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: aplastic anaemia, cardio-respiratory arrest, erythema, erythema infectiosum, haemolysis, hepatitis toxic, hypotension, interstitial lung disease. Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #5338472-0
Daclizumab side effect was reported by a Health Professional from UNITED STATES on May 22, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, hypereosinophilic syndrome, interstitial lung disease, meningitis , pneumonitis, pyrexia, rash . Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5353764-7
Daclizumab side effect was reported by a Health Professional from UNITED STATES on June 02, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis , pneumonitis, pyrexia, rash . Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5358853-9
Daclizumab side effect was reported by a Health Professional from UNITED STATES on June 08, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis , pneumonitis, pyrexia, rash . Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5397608-6
Daclizumab side effect was reported by a Health Professional from UNITED STATES on July 17, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis , pneumonitis, pyrexia, rash . Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5478449-8
Daclizumab side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis , pneumonitis, pyrexia, rash . Daclizumab dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYLOESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.